NCT02259842View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

BI 34021 FU2 solution

DRUG

BI 34021 FU2 tablet

dose group 4 only

DRUG

Placebo

OTHER

High fat, high calorie breakfast

only for dose groups 3 and 5

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY